Travere Therapeutics, Inc. TVTX Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s operating lease liabilities (total)?
- Travere Therapeutics, Inc. (TVTX) reported operating lease liabilities (total) of $15.58M in Q1 2026.
- How has Travere Therapeutics, Inc.'s operating lease liabilities (total) changed year-over-year?
- Travere Therapeutics, Inc.'s operating lease liabilities (total) decreased by 25.9% year-over-year, from $21.04M to $15.58M.
- What is the long-term trend for Travere Therapeutics, Inc.'s operating lease liabilities (total)?
- Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s operating lease liabilities (total) has grown at a -13.2% compound annual growth rate (CAGR), from $34.5M to $17.01M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.